
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review. | ||
| provenance review | not_started | Recent-death rule: only facts Cash, his manager, or published reference works made public are used. Encyclopedia of Arkansas, ABC News, CNN transcript, and Pollstar logged. | ||
| safe messaging review | not_started | Historical substance use is recorded as history, marked sensitive, and is not a modern diagnosis. Death recorded without graphic detail. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-03-27 Progress note 02 (C-CDA) | Tonometry (eye pressure) | Every glaucoma visit; 4 to 6 weeks after adding a drop | Not measured at this visit, and no eye-clinic check has been booked since dorzolamide was added four weeks ago, a deviation from the plan. Request sent to the eye clinic |
| 2026-05-29 Progress note 04 (C-CDA) | ALT, AST, and platelets for FIB-4 | At diagnosis and yearly | FIB-4 could not be calculated at intake because no platelet count was drawn with the hemoglobin, a deviation from the protocol. ALT and AST were normal at intake and ALT is normal today, so missed liver scarring is unlikely; AST and a platelet count are added to the annual tests |
| 2026-05-29 Progress note 04 (C-CDA) | Lipoprotein(a) | Once in adulthood | Not yet measured, a deviation from the protocol. It would not change treatment now, since he already takes a high-intensity statin; added to the annual lipid panel |
| 2026-08-14 Progress note 05 (C-CDA) | Visual field (Humphrey 10-2) | In advanced disease, alongside the 24-2 | Not done at intake or today, a deviation from the protocol for severe glaucoma. The 24-2 and OCT are stable, so loss near fixation is unlikely to have been missed; the eye clinic will add a 10-2 at the next field visit |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-04-24 Progress note 03 (C-CDA) | Prevention | Falls prevention | Referred | Physical therapy for gait and balance and low-vision rehabilitation for home safety |
| 2026-04-24 Progress note 03 (C-CDA) | Prevention | Colorectal cancer screening | Ordered | No screening result on file; stool FIT kit given, to be returned by mail |
| 2026-04-24 Progress note 03 (C-CDA) | Prevention | Hepatitis C screening | Ordered | One-time screening recommended for all adults through age 79; added to the three-month laboratory tests |
| 2026-08-14 Progress note 05 (C-CDA) | Referral | Diabetes self-management education and medical nutrition therapy | Referred | Not arranged in the first six months despite two medication changes, a deviation from the protocol. No harm resulted, since HbA1c reached goal without hypoglycemia. Referred today to an individual program with large-print materials because of his vision |
None.
| Claim | Grade | Statement |
|---|---|---|
| CLM-0004 | D | In 1957 Cash began taking amphetamines to stay awake on a long road trip, the start of an addiction that lasted about a decade; in a 2002 interview he named amphetamines and barbiturates in the 1960s. |
| CLM-0005 | D | Cash was hospitalized in 1983 with internal bleeding; after recovering he entered the Betty Ford Clinic for treatment. |
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-02-27 | HbA1c | 8.6% (high) | High |
| 2026-02-27 | Glucose | 186 mg/dL (high) | High |
| 2026-02-27 | LDL cholesterol | 128 mg/dL (high) | High |
| 2026-02-27 | Intraocular pressure, right eye | 22 mmHg (high) | High |
| 2026-02-27 | Intraocular pressure, left eye | 24 mmHg (high) | High |
| 2026-02-27 | Mean RNFL thickness by OCT, right eye | 61 um (low) | Low |
| 2026-02-27 | Mean RNFL thickness by OCT, left eye | 57 um (low) | Low |
| 2026-02-27 | Best-corrected visual acuity, right eye (ETDRS letters) | 68 (low) | Low |
| 2026-02-27 | Best-corrected visual acuity, left eye (ETDRS letters) | 63 (low) | Low |
| 2026-03-27 | Glucose | 152 mg/dL (high) | High |
| 2026-05-29 | HbA1c | 7.7% (high) | High |
| 2026-08-14 | HbA1c | 7.3% (high) | High |
| 2026-08-14 | Glucose | 131 mg/dL (high) | High |
| 2026-08-14 | Mean RNFL thickness by OCT, right eye | 60 um (low) | Low |
| 2026-08-14 | Mean RNFL thickness by OCT, left eye | 57 um (low) | Low |
| 2026-08-14 | Best-corrected visual acuity, right eye (ETDRS letters) | 68 (low) | Low |
| 2026-08-14 | Best-corrected visual acuity, left eye (ETDRS letters) | 62 (low) | Low |